Michaela Feriancova

Dr. Michaela Feriancova


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
VFVladimír Ferianec
Vladimír Ferianec
MFMatej Fülöp
Matej Fülöp
MJMiriam Ježovičová
Miriam Ježovičová
JRJana Radosinska
Jana Radosinska
MKMarta Kollárová
Marta Kollárová
Zdenka ĎuračkováZdenka Ďuračková
Zdenka Ďuračková
Hysterectomy has a variety of medical indications and improves pre-operative symptoms but might compromise the quality of life during recovery due to symptoms such as fatigue, headache, nausea, depression, or pain. The aim of the present study was to determine the effect of a standardized extract from French oak wood (Quercus robur) containing at least 40% polyphenols of the ellagitannins class, Robuvit®, on convalescence and oxidative stress of women after hysterectomy. Recovery status was monitored with the SF-36 questionnaire. The supplementation with Robuvit® (300 mg/day) during 4 weeks significantly improved general and mental health, while under placebo some items significantly deteriorated. Oxidative stress and enhancement of MMP–9 activity was significantly reduced by Robuvit® versus placebo. After 8 weeks of intervention, the patients’ condition improved independently of the intervention. Our results suggest that the use of Robuvit® as a natural supplement relieves post-operative symptoms of patients after hysterectomy and reduces oxidative stress. The study was registered with ID ISRCTN 11457040 (13/09/2019).

17 June 2017 in Clinical & Experimental Metastasis
Verified
Journal Article
Closed access
PDF file
MFMichaela Feriancova
Michaela Feriancova
JHJ. Hlavaty
J. Hlavaty
Yen TanYen Tan
Yen Tan
CSC. Singer
C. Singer
KPKamil Pohlodek
Kamil Pohlodek
IWI. Walter
I. Walter

1 January 2021 in Neoplasma
Verified
Journal Article
Closed access
MFMichaela Feriancova
Michaela Feriancova
IWIngrid Walter
Ingrid Walter
CSChristian F. Singer
Christian F. Singer
JGJuraj Gazdarica
Juraj Gazdarica
KPKamil Pohlodek
Kamil Pohlodek
Expression of COX-2, p16, and Ki67 in the range from normal breast tissue to breast cancer

18 November 2013 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
VFVladimír Ferianec
Vladimír Ferianec
MFMichaela Feriancova
Michaela Feriancova
Beckwith–Wiedemann syndrome (BWS) is an overgrowth syndrome known as exomphalos-macroglossia – gigantism syndrome. Prognosis is good, prenatal diagnosis is important for pregnancy management but might be difficult due to clinical overlap with other syndromes. Perlman syndrome is an overgrowth syndrome with high perinatal mortality, most frequent antenatal findings include polyhydramnios, macrosomia, visceromegaly, nephromegaly and foetal ascites. Authors present a case of prenatally diagnosed BWS with severe ascites as first antenatal finding and lethal course, signs more typical of Perlman syndrome. This combination of clinical signs has not been published yet and may contribute to specification of possible prenatal manifestation of BWS.

5 May 2022 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
VFVladimír Ferianec
Vladimír Ferianec
MKMarián Križko
Marián Križko
MGMartin Gábor
Martin Gábor
PPPeter Papcun
Peter Papcun
MAMartin Alföldi
Martin Alföldi
MFMichaela Feriancova
Michaela Feriancova
To assess the use of amniopatch – intraamniotic application of maternal platelets and cryoprecipitate, in patients after spontaneous previable rupture of membranes (sPPPROM) in terms of its effect ...